Liyan Chen
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Heat shock proteins research 3
- Genomics, phytochemicals, and oxidative stress 2
- Wnt/β-catenin signaling in development and cancer 2
-
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Zhenhua Lin (13 shared papers)Jie Sun (5 shared papers)Junjie Piao (5 shared papers)Tiefeng Jin (6 shared papers)Ming Xu (5 shared papers)Xuelian Cui (2 shared papers)Qunying Wu (2 shared papers)Shuangping Liu (2 shared papers)
- Journals
- Oncotarget (3 papers)Cancer Management and Research (2 papers)BioMed Research International (2 papers)PLoS ONE (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)
- Partner nations
- ChinaSouth KoreaJapan
In The Last Decade
Liyan Chen
31 papers receiving 860 citations
Peers
Comparison fields: 5 of 88
- Toxicology 68
- Cancer Research 112
- Cell Biology 116
- Molecular Biology 480
- Oncology 121
Countries citing papers authored by Liyan Chen
This map shows the geographic impact of Liyan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Chen more than expected).
Fields of papers citing papers by Liyan Chen
This network shows the impact of papers produced by Liyan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Chen. The network helps show where Liyan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Liyan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 150 | |
| 2 | 2019 | 95 | |
| 3 | 2012 | 50 | |
| 4 | 2016 | 46 | |
| 5 | 2019 | 43 | |
| 6 | 2017 | 42 | |
| 7 | 2022 | 41 | |
| 8 | 2017 | 39 | |
| 9 | 2016 | 38 | |
| 10 | 2017 | 31 | |
| 11 | 2019 | 30 | |
| 12 | 2021 | 27 | |
| 13 | 2022 | 26 | |
| 14 | 2017 | 21 | |
| 15 | Antitumor activity of the novel HDAC inhibitor CUDC-101 combined with gemcitabine in pancreatic cancer. | 2018 | 20 |
| 16 | 2022 | 19 | |
| 17 | 2019 | 19 | |
| 18 | 2017 | 18 | |
| 19 | 2019 | 18 | |
| 20 | 2019 | 15 |
About Liyan Chen
Liyan Chen is a scholar working on Molecular Biology, Epidemiology, Cancer Research, Oncology and Pharmacology, having authored 32 papers that have together received 863 indexed citations. Recurring topics across this work include Heat shock proteins research (3 papers), Cancer, Lipids, and Metabolism (3 papers), Flavonoids in Medical Research (3 papers), Microtubule and mitosis dynamics (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Cancer-related Molecular Pathways (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Toxicology (68 citations), Cancer Research (112 citations), Cell Biology (116 citations), Molecular Biology (480 citations) and Oncology (121 citations). Liyan Chen has collaborated with scholars based in China, South Korea and Japan. Frequent co-authors include Zhenhua Lin, Jie Sun, Junjie Piao, Tiefeng Jin, Ming Xu, Xuelian Cui, Qunying Wu, Shuangping Liu, Yan Zhang and Yang� Yang. Their work appears in journals such as Oncotarget, Cancer Management and Research, BioMed Research International, PLoS ONE and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.